Zobrazeno 1 - 10
of 280
pro vyhledávání: '"Hoogendijk, R."'
Autor:
Peirelinck H; Belgian Cancer Registry, Brussels, Belgium., Schulpen M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hoogendijk R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Van Damme A; Department of Pediatric Hematology and Oncology, Saint Luc University Hospital, Brussels, Belgium., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Utrecht, Utrecht, The Netherlands., Henau K; Belgian Cancer Registry, Brussels, Belgium., Van Damme N; Belgian Cancer Registry, Brussels, Belgium., Karim-Kos HE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Jul 15; Vol. 155 (2), pp. 226-239. Date of Electronic Publication: 2024 Mar 13.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
van Maren, E. A., Dankbaar, J. W., Wesseling, P., Plasschaert, S., Muhlebner, A., Hoving, E. W., Robe, P. A., Snijders, T. J., Hoogendijk, R., Kranendonk, M. E. G., Lequin, M. H.
Publikováno v:
American Journal of Neuroradiology; Jun2024, Vol. 45 Issue 6, p747-752, 6p
Autor:
van Maren EA; From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands., Dankbaar JW; From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands j.w.dankbaar@umcutrecht.nl., Wesseling P; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands.; Department of Pathology (P.W.), Amsterdam University Medical Centers/VU Medical Center, Amsterdam, the Netherlands., Plasschaert S; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands., Muhlebner A; Department of Pathology (A.M.), University Medical Center Utrecht, Utrecht, the Netherlands., Hoving EW; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands.; Department of Neurosurgery (E.W.H., P.A.R.), University Medical Center Utrecht, Utrecht, the Netherlands., Robe PA; Department of Neurosurgery (E.W.H., P.A.R.), University Medical Center Utrecht, Utrecht, the Netherlands., Snijders TJ; Department of Neurology (T.J.S.), UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands., Hoogendijk R; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands., Kranendonk MEG; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands., Lequin MH; From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands.
Publikováno v:
AJNR. American journal of neuroradiology [AJNR Am J Neuroradiol] 2024 Jun 07; Vol. 45 (6), pp. 747-752. Date of Electronic Publication: 2024 Jun 07.
Autor:
Hoogendijk R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: r.hoogendijk@prinsesmaximacentrum.nl., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kranendonk MEG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Gatta G; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Capocaccia R; Editorial Board, Epidemiol Prev, Milan, Italy., Hoving EW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Neurosurgery, University Medical Center Utrecht, Utrecht, the Netherlands., Wesseling P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Visser O; Department of Research and Innovation, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., van Vuurden DG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Karim-Kos H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Research and Innovation, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands. Electronic address: h.e.karim-kos@prinsesmaximacentrum.nl.
Publikováno v:
STAR protocols [STAR Protoc] 2024 Mar 15; Vol. 5 (1), pp. 102905. Date of Electronic Publication: 2024 Feb 22.
Publikováno v:
In Control Engineering Practice April 2015 37:20-31
Publikováno v:
In Mechatronics September 2014 24(6):632-639
Autor:
Ausejo-Mauleon I; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Labiano S; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., de la Nava D; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Laspidea V; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Zalacain M; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Marrodán L; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., García-Moure M; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., González-Huarriz M; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Hervás-Corpión I; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Dhandapani L; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Vicent S; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain., Collantes M; Radiopharmacy Unit, Clínica Universidad de Navarra, Pamplona, Spain; Translational Molecular Imaging Unit, Clínica Universidad de Navarra, Pamplona, Spain., Peñuelas I; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Radiopharmacy Unit, Clínica Universidad de Navarra, Pamplona, Spain; Translational Molecular Imaging Unit, Clínica Universidad de Navarra, Pamplona, Spain., Becher OJ; Jack Martin Fund Division of Pediatric Hematology-oncology, Mount Sinai, New York, NY, USA., Filbin MG; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Jiang L; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Labelle J; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., de Biagi-Junior CAO; Department of Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Nazarian J; Children's National Health System, Center for Genetic Medicine Research, Washington, DC, USA; Virginia Tech University, Washington, DC, USA; Division of Oncology and Children's Research Center, DIPG/DMG Research Center Zurich, University Children's Hospital Zurich, Zurich, Switzerland., Laternser S; Division of Oncology and Children's Research Center, DIPG/DMG Research Center Zurich, University Children's Hospital Zurich, Zurich, Switzerland., Phoenix TN; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA., van der Lugt J; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kranendonk M; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hoogendijk R; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Mueller S; University of California, San Francisco, San Francisco, CA, USA., De Andrea C; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain., Anderson AC; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Guruceaga E; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Bioinformatics Platform, CIMA-Universidad de Navarra, Pamplona, Spain., Koschmann C; Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA., Yadav VN; Department of Pediatrics, University of Missouri Kansas City School of Medicine, Kansas City, KS, USA; Department of Pediatrics, Children's Mercy Research Institute (CMRI), Kansas City, KS, USA; Department of Cancer Biology, University of Kansas Cancer Center. Kansas City, KS, USA., Gállego Pérez-Larraya J; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain., Patiño-García A; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain., Pastor F; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Molecular Therapeutics Program, CIMA-Universidad de Navarra, Pamplona, Spain., Alonso MM; Health Research Institute of Navarra (IdiSNA), Pamplona, Spain; Solid Tumor Program, CIMA-Universidad de Navarra, Pamplona, Spain; Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain. Electronic address: mmalonso@unav.es.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Nov 13; Vol. 41 (11), pp. 1911-1926.e8. Date of Electronic Publication: 2023 Oct 05.
Autor:
Rubio-San-Simón A; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands. arubiosansimon@gmail.com.; Department of Pediatric Oncology/Hematology, Niño Jesús Children's Hospital, Madrid, Spain. arubiosansimon@gmail.com., van Eijkelenburg NKA; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., Hoogendijk R; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., Hasle H; Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark., Niemeyer CM; Department of Pediatric Hematology and Oncology, Center for Pediatrics, Medical Center, University of Freiburg, Freiburg, Germany., Dworzak MN; St. Anna Children's Cancer Research Institute, Vienna, Austria.; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria., Zecca M; Department of Pediatric Hematology-Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Lopez-Yurda M; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Biometrics, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Janssen JM; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pharmacology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., Laille EJ; Cellectis, New York, NY, USA.; Bristol Myers Squibb/Celgene, Summit, NJ, USA., van Tinteren H; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., Zwaan CM; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.; European Consortium for Innovative Therapies for Children with Cancer (ITCC), Villejuif, France.
Publikováno v:
Paediatric drugs [Paediatr Drugs] 2023 Nov; Vol. 25 (6), pp. 719-728. Date of Electronic Publication: 2023 Sep 11.
Autor:
Hoogendijk R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Baugh J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kline C; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Kranendonk M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Hoving E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Neurosurgery, University Medical Center Utrecht, Utrecht, the Netherlands., Kremer L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pediatrics, Emma Children's Hospital/ Amsterdam University Medical Center/AMC, Amsterdam, the Netherlands., Wesseling P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Pathology, Amsterdam University Medical Centers/VUmc, Amsterdam, the Netherlands., Karim-Kos H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Research and Innovation, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., van Vuurden D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Publikováno v:
IScience [iScience] 2023 Sep 17; Vol. 26 (10), pp. 107957. Date of Electronic Publication: 2023 Sep 17 (Print Publication: 2023).